TY - JOUR
T1 - Reduced renal function and sleep-disordered breathing in community-dwelling elderly men
AU - Canales, Muna T.
AU - Taylor, Brent C.
AU - Ishani, Areef
AU - Mehra, Reena
AU - Steffes, Michael
AU - Stone, Katie L.
AU - Redline, Susan
AU - Ensrud, Kristine E.
PY - 2008/8
Y1 - 2008/8
N2 - Background: Sleep-disordered breathing (SDB) may increase the risk of cardiovascular disease (CVD) and death in chronic kidney disease (CKD). However, the association between mild reductions in renal function and SDB is uncertain. Methods: We studied 508 community-dwelling men aged ≥67 years (mean 76.0 ± 5.3) who were enrolled at the Minnesota site for the Minneapolis center of the Outcomes of Sleep Disorders in Older Men (MrOS) sleep study and had serum cystatin-C and creatinine measured coincident with overnight polysomnography. CKD was defined as estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2 using Cockcroft-Gault (CG), modification of diet in renal disease (MDRD) and Mayo Clinic formulae. SDB was defined by a respiratory disturbance index (RDI) ≥15 events/h. Results: Mean cystatin-C was 1.21 ± 0.30 mg/L, and mean creatinine was 1.09 ± 0.23 mg/dL. Median RDI was 7.0 events/h (range 0-73). Higher quartiles of cystatin-C were associated with higher mean RDI (p for trend = 0.007). This association persisted after adjustment for age and race (p for trend = 0.03), but not after adjustment for body mass index (BMI, p for trend = 0.34). After adjusting for age, race, BMI, diabetes, hypertension, and CVD, CKD defined by the Mayo Clinic formula, but not CG or MDRD, was associated with a higher odds of SDB [odds ratio (OR) 1.95, 95% confidence interval (CI) 1.04-3.65, p = 0.04]. Conclusions: Older men with reduced renal function as defined by higher cystatin-C concentration have higher average RDI. This effect is explained by higher BMI in men with higher cystatin-C. CKD defined by the Mayo Clinic formula is independently associated with twofold higher odds for SDB. Therefore, reduced renal function may be associated with SDB in older men.
AB - Background: Sleep-disordered breathing (SDB) may increase the risk of cardiovascular disease (CVD) and death in chronic kidney disease (CKD). However, the association between mild reductions in renal function and SDB is uncertain. Methods: We studied 508 community-dwelling men aged ≥67 years (mean 76.0 ± 5.3) who were enrolled at the Minnesota site for the Minneapolis center of the Outcomes of Sleep Disorders in Older Men (MrOS) sleep study and had serum cystatin-C and creatinine measured coincident with overnight polysomnography. CKD was defined as estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2 using Cockcroft-Gault (CG), modification of diet in renal disease (MDRD) and Mayo Clinic formulae. SDB was defined by a respiratory disturbance index (RDI) ≥15 events/h. Results: Mean cystatin-C was 1.21 ± 0.30 mg/L, and mean creatinine was 1.09 ± 0.23 mg/dL. Median RDI was 7.0 events/h (range 0-73). Higher quartiles of cystatin-C were associated with higher mean RDI (p for trend = 0.007). This association persisted after adjustment for age and race (p for trend = 0.03), but not after adjustment for body mass index (BMI, p for trend = 0.34). After adjusting for age, race, BMI, diabetes, hypertension, and CVD, CKD defined by the Mayo Clinic formula, but not CG or MDRD, was associated with a higher odds of SDB [odds ratio (OR) 1.95, 95% confidence interval (CI) 1.04-3.65, p = 0.04]. Conclusions: Older men with reduced renal function as defined by higher cystatin-C concentration have higher average RDI. This effect is explained by higher BMI in men with higher cystatin-C. CKD defined by the Mayo Clinic formula is independently associated with twofold higher odds for SDB. Therefore, reduced renal function may be associated with SDB in older men.
KW - Chronic kidney disease
KW - Cystatin-C
KW - Kidney dysfunction
KW - Sleep apnea syndromes
KW - Sleep disorders
KW - Sleep-disordered breathing
UR - http://www.scopus.com/inward/record.url?scp=48449104687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=48449104687&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2007.08.021
DO - 10.1016/j.sleep.2007.08.021
M3 - Article
C2 - 18819173
AN - SCOPUS:48449104687
VL - 9
SP - 637
EP - 645
JO - Sleep Medicine
JF - Sleep Medicine
SN - 1389-9457
IS - 6
ER -